BCG for Superficial Bladder Cancer
Links shared publicly online about this topic
The Management Of BCG Failure In Non-muscle-invasive Bladder Cancer: An Update
medicalnewstoday.com — “UroToday.com - A major dilemma among patients with non-muscle-invasive bladder cancer (NMIBC) and their physicians is the choice of an appropriate course of action following failure of intravesica” View full resource at medicalnewstoday.com
Most Recently Shared on June 14, 2010 at 1:05 pm By:
The Management Of BCG Failure In Non-muscle-invasive Bladder Cancer: An Update http://mnt.to/3DPs #urology
Trial Backs Maintenance BCG for Bladder Cancer - QualityPoint Technologies
qualitypointtech.net — “Patients with non-muscle-invasive bladder cancers have a clear recurrence-free survival advantage from long-term therapy with bacillus Calmette-Guerin (BCG) therapy after resection, a new multicenter study confirms. Reuters Health Information” View full resource at qualitypointtech.net
Most Recently Shared on January 6, 2011 at 7:00 pm By:
Trial Backs Maintenance BCG for Bladder Cancer: Patients with non-muscle-invasive bladder cancers have a clear rec... http://bit.ly/h5A84K
FDA approves continuation of Phase IIb clinical trial for superficial bladder cancer
news-medical.net — “Tikcro Technologies Ltd. today announced that BioCancell Therapeutics, Inc., concluded the first 18 patient group treated pursuant to a Phase IIb clinical trial of the drug candidate BC-819 for use in superficial bladder cancer. These patients had not responded to conventional treatment.” View full resource at news-medical.net
Most Recently Shared on May 3, 2010 at 5:48 pm By:
Ovarian Cancer News: FDA approves continuation of Phase IIb clinical trial for superficial bladder cancer: Tikcr... http://buzzup.com/vyot
Superficial Papillary Tumor (Images) - Bladder Cancer - Urology Channel
urologychannel.com — “These images show superficial papillary tumors of the bladder. The image on the top left shows a tumor in a divertuculum within the bladder wall.” View full resource at urologychannel.com
Most Recently Shared on September 27, 2010 at 2:48 pm By:
Susan Scroggins Active Health Library and Health Advocate
Just added http://bit.ly/cAYpkU to the Superficial Papillary Tumor Images WisdomCard http://bit.ly/ceK1AZ @organizedwisdom
TRPV2 Activation Induces Apoptotic Cell Death In Human T24 Bladder Cancer Cells: A Potential Therapeutic Target For Bladder Cancer
medicalnewstoday.com — “Bladder carcinoma is the second most common malignancy of the urinary tract and nearly 90% of all primary tumors of the bladder are urothelial carcinomas (UCs). Superficial UCs can be shaved off” View full resource at medicalnewstoday.com
Most Recently Shared on August 11, 2010 at 10:41 am By:
Urology & Nephrology OW Health
TRPV2 Activation Induces Apoptotic Cell Death In Human T24 Bladder Cancer Cells: A Potential Therapeutic Target Fo... http://mnt.to/f/3HcT
Gemcitabine May Hold Promise for BCG Failures in Bladder Cancer Patients - Renal and Urology News
renalandurologynews.com — “Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Gurin (BCG), according to Italian researchers.” View full resource at renalandurologynews.com
Most Recently Shared on February 25, 2010 at 2:32 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Gemcitabine May Hold Promise for BCG Failures in Bladder Cancer Patients: Gemcitabine might be a second-line treat... http://bit.ly/bgwU3B
Bladder cancer : The Lancet
thelancet.com — “Bladder cancer. By - Prof, Dr Donald S Kaufman MD, Prof William U Shipley MD, Adam S Feldman MD” View full resource at thelancet.com
Most Recently Shared on July 20, 2009 at 8:56 pm By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Bladder cancer - http://bit.ly/1RZQ0j
Oncology Article | bladder cancer
mdlinx.com — “Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery” View full resource at mdlinx.com
Most Recently Shared on June 28, 2011 at 3:03 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and bioma... http://bit.ly/jXnNyk #oncology
Induction BCG Sufficient for High-Risk NMIBC - Renal and Urology News
renalandurologynews.com — “Bacillus Calmette-Gu©rin (BCG) treatment without maintenance in patients with high-risk non-muscle-invasive bladder cancer (NMIBC) compares favorably with trials in which comparable patients received maintenance BCG.” View full resource at renalandurologynews.com
Most Recently Shared on May 5, 2011 at 6:01 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Induction BCG Sufficient for High-Risk NMIBC: Bacillus Calmette-Guérin (BCG) treatment without maintenance in pa... http://bit.ly/lsTIZf
Drug May Be an Alternative to Cystectomy for BCG Failures - Renal and Urology News
renalandurologynews.com — “VIENNA--"Mycobacterial cell wall DNA complex (MCC) may provide an alternative to cystectomy for patients with non-muscle invasive bladder cancer refractory to bacillus Calmette-Gu©rin (BCG) treatment, according to preliminary study findings.” View full resource at renalandurologynews.com
Most Recently Shared on March 21, 2011 at 12:06 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Drug May Be an Alternative to Cystectomy for BCG Failures: VIENNA—Mycobacterial cell wall DNA complex (MCC) may ... http://bit.ly/hfiFqe
Gemcitabine May Hold Promise for BCG Failures - Renal and Urology News
renalandurologynews.com — “Gemcitabine might be a second-line treatment option for patients with high-risk non-muscle-invasive bladder cancer (BC) who fail therapy with bacille Calmette-Gurin (BCG), according to Italian researchers.” View full resource at renalandurologynews.com
Most Recently Shared on March 30, 2010 at 5:14 pm By:
Renal Urology News Urology, Medical Publisher, Health News, and Nephrology
Gemcitabine May Hold Promise for BCG Failures: Gemcitabine might be a second-line treatment option for patients wi... http://bit.ly/cOMQcN
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors - OncologySTAT
oncologystat.com — “J Clin Oncol. 2010 Apr 26; Epub Ahead of Print - Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors” View full resource at oncologystat.com
Most Recently Shared on May 20, 2010 at 1:30 pm By:
OncologySTAT Health Site and Oncology
Story of the Week With Expert Commentary: E2F1 Expression Predicts Progression to Invasive Bladder Cancer http://tinyurl.com/3xumnpy
Urinary Bladder on #MDlinx
mdlinx.com — “Urinary Bladder on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 15, 2010 at 8:34 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A comparison of two BCG instillation regimens for non-muscle invasive bladder cancer: A retrospective coho... http://bit.ly/9khHbW #urology
Phase 3 study of Urocidin for bladder cancer - MPR
empr.com — “Bioniche Life Sciences announced that it has completed recruitment in its initial Phase 3 registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guerin (BCG).” View full resource at empr.com
Most Recently Shared on March 31, 2009 at 11:11 pm By:
Phase 3 study of Urocidin for bladder cancer : Bioniche Life Sciences announced that it has completed recruitmen.. http://tinyurl.com/cfe9ln
Valstar available again for treatment of bladder cancer - MPR
empr.com — “Endo Pharmaceuticals has launched Valstar (valrubicin), an anthracycline derivative, for the treatment of Bacille Calmette-Guerin (BCG)-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality.” View full resource at empr.com
Most Recently Shared on September 3, 2009 at 3:18 pm By:
MPR News: Valstar available again for treatment of bladder cancer: Endo Pharmaceuticals has launched Va.. http://bit.ly/QfV2Z
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Urology
The latest urology/nephrology news published daily. Articles from research centers, universities and prestigious journals.
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
News-Medical.Net
Stay up to date with the latest Ovarian Cancer news and research via News-Medical.Net
Advertisement
